Literature DB >> 27989364

Complications in the surgical management of children with malignant solid tumors.

Andrew M Davidoff1, Israel Fernandez-Pineda2.   

Abstract

With improvement in the outcomes for children with cancer has come an increasing focus on minimizing the morbidity from therapeutic interventions, including surgical procedures, while continuing to have a high likelihood of cure. Thus, an appreciation for the potential complications of surgery, both acute and long term, is critical when considering the risks and benefits of any procedure performed on a child with cancer. Although not meant to be an exhaustive review, here we discuss the most common and significant surgical complications that may occur when performing diagnostic, therapeutic, or supportive procedures in children with the most common malignant solid tumors.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complications; Neuroblastoma; Pediatric cancer; Sarcoma; Surgery; Wilms tumor

Mesh:

Year:  2016        PMID: 27989364     DOI: 10.1053/j.sempedsurg.2016.10.003

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  3 in total

1.  Fibrin Gels Entrapment of a Poly-Cyclodextrin Nanocarrier as a Doxorubicin Delivery System in an Orthotopic Model of Neuroblastoma: Evaluation of In Vitro Activity and In Vivo Toxicity.

Authors:  Maurizio Viale; Graziella Vecchio; Massimiliano Monticone; Vittorio Bertone; Valentina Giglio; Irena Maric; Michele Cilli; Vittorio Bocchini; Aldo Profumo; Mirco Ponzoni; Laura Emionite; Mattia Rocco
Journal:  Pharm Res       Date:  2019-06-03       Impact factor: 4.200

2.  Early postoperative complications in pediatric abdominal solid tumor surgery according to Clavian-Dindo classification.

Authors:  İdil Rana User; Burak Ardıçlı; Arbay Özden Çiftçi; İbrahim Karnak; Feridun Cahit Tanyel; Berna Oğuz; Mithat Haliloğlu; Tezer Kutluk; Ali Varan; Saniye Ekinci
Journal:  Pediatr Surg Int       Date:  2022-07-12       Impact factor: 2.003

3.  CD133 expression and MYCN amplification induce chemoresistance and reduce average survival time in pediatric neuroblastoma.

Authors:  Zhi-Yong Zhong; Bao-Jun Shi; Hui Zhou; Wen-Bo Wang
Journal:  J Int Med Res       Date:  2018-01-11       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.